Transforming growth factor-beta1 (TGF-beta1) gene polymorphism in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 190s Year: 2006
Transforming growth factor-β1 gene polymorphism and susceptibility to idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005
Pleural fibrosis induced by transforming growth factor (TGF)-β1 gene transfer Source: Eur Respir J 2005; 26: Suppl. 49, 100s Year: 2005
Interdependence of endothelin-1 and transforming growth factor-β1 on Wnt3a expression in idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012
Association of transforming growth factor-ß1 and angiotensinogen G-6A gene polymorphisms influences idiopathic pulmonary fibrosis disease progression Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010
Transforming growth factor-? gene polymorphisms in different phenotypes of sarcoidosis Source: Eur Respir J 2011; 37: 169-175 Year: 2011
Tissue plasminogen activator decreased the expression of fibrogenic cytokines by doxycycline and transforming growth factor-beta in MeT-5A Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010
Expression and functional analysis of the transforming growth factor (TGF)-β superfamily in pulmonary arterial hypertension: role of PAI-1 in disease progression Source: Eur Respir J 2007; 30: Suppl. 51, 53s Year: 2007
Transforming growth factor-beta 1 (TGF-beta1) gene polymorphism in coincidence with some other host and environmental factors is associated with irreversible bronchoconstriction in asthmatics Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006
Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007
The protease activated receptor (PAR)-2/tissue factor/coagulation factor VIIa axis in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010
Wnt11 inhibits effects of transforming growth factor-beta1 (TGFbeta1) on lung epithelial phenotype Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013
Altered expression of the Smad signalling pathway: implications for COPD pathogenesis Source: Eur Respir J 2006; 28: 533-541 Year: 2006
MMP-12 activates protease activated receptor (PAR)-1, upregulates placenta growth factor and leads to pulmonary emphysema Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018
Transforming growth factor beta (TGFβ)-2 and -3 gene polymorphisms in different phenotypes of sarcoidosis Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009
The contribution of transforming growth factor-β and epidermal growth factor signalling to airway remodelling in chronic asthma Source: Eur Respir J 2006; 27: 208-229 Year: 2006
The expression of transforming growth factor-β inducible gene-h3 in the course of lipopolysaccharide-induced lung injury Source: Eur Respir J 2006; 28: Suppl. 50, 398s Year: 2006
The role of integrins in pulmonary fibrosis Source: Eur Respir Rev 2008; 17: 157-162 Year: 2008
Increased expression of epidermal growth factor-receptor in idiopathic interstitial pneumonias. A tissue microarray study Source: Eur Respir J 2007; 30: Suppl. 51, 573s Year: 2007
Expression of transforming growth factor (TGF) in bronchial epithelium: association with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 92s Year: 2001